
Airglove Medical has launched Airglove v2, an air‑warming glove designed to improve vein physiology before venepuncture. Clinical evaluations across more than 150 UK hospitals reported an 87.5% first‑time cannulation rate in oncology patients, a group known for difficult IV access. The UK performs roughly 32 million cannulations annually, with a 30% first‑attempt failure rate, positioning the patented system as a potential market disruptor. By gently heating the arm, the device dilates veins, aiming to make cannulation faster, easier, and less painful.
MD&M West 2026 convened over 1,700 exhibitors and more than 13,000 attendees in Anaheim, showcasing the latest in medical device manufacturing. Thirteen on‑site interviews highlighted digital transformation, smart manufacturing, advanced materials, and precision tooling across a spectrum of companies. Notable...

The MHRA has opened a public consultation proposing that CE‑marked medical devices be recognised indefinitely in Great Britain. Around 90% of devices used in the GB market currently carry a CE mark, and the agency aims to align transition timelines...